Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.48	146.21	44.98	52.74	44.21	114.61
Trading Asset Securities	44.71	43.81	162.38	305.12	424.08	472.45
Cash & Short-Term Investments	141.19	190.02	207.35	357.87	468.29	587.07
Cash Growth	-18.51%	-8.36%	-42.06%	-23.58%	-20.23%	-14.67%
Accounts Receivable	303.26	261.4	273.97	222.76	154.61	131.31
Other Receivables	3.41	3.17	3.09	6.82	5.99	3.63
Receivables	306.67	264.57	277.06	229.57	160.61	134.94
Inventory	93.13	95.1	111.79	115.33	103.42	71.17
Other Current Assets	0.96	1.14	2.09	2.74	1.14	0.68
Total Current Assets	541.94	550.83	598.29	705.5	733.46	793.86
Property, Plant & Equipment	810.91	811.19	823.31	776.66	768.55	642.76
Long-Term Investments	16.59	6.58	1.59	1.58	1.57	1.57
Other Intangible Assets	100.32	102.66	93.6	53.12	32.66	33.23
Long-Term Deferred Tax Assets	13.49	13.26	5.14	6.5	7.08	8.39
Long-Term Deferred Charges	36.94	33.18	42.35	42.17	35.52	1.88
Other Long-Term Assets	40.46	36.41	29.72	19.56	19.62	32.78
Total Assets	1,561	1,554	1,594	1,605	1,598	1,514
Accounts Payable	9.11	5.44	5.14	8.86	11.33	7.54
Accrued Expenses	6.59	57.82	42.8	48.37	58.72	55.7
Short-Term Debt	14.01	14.01	-	-	-	-
Current Portion of Leases	0.6	0.48	0.33	0.14	0.13	-
Current Income Taxes Payable	3.63	-	0.23	7.58	5.09	1.01
Current Unearned Revenue	17.3	19.59	6.65	10.61	8.92	14.58
Other Current Liabilities	77.16	18.86	21.35	21.66	29.33	27.05
Total Current Liabilities	128.4	116.2	76.5	97.22	113.53	105.87
Long-Term Leases	1.44	1.01	0.92	0.31	0.38	-
Long-Term Unearned Revenue	10.59	11.08	9.49	10.36	11.3	12.22
Long-Term Deferred Tax Liabilities	0.35	0.21	0.02	0.32	0.27	0.11
Total Liabilities	140.77	128.5	86.93	108.21	125.48	118.2
Common Stock	410.64	410.64	410.64	410.64	410.64	409.7
Additional Paid-In Capital	539.23	539.23	539.23	546.04	552.18	539.92
Retained Earnings	476.72	479.74	538.85	540.19	516.05	446.79
Treasury Stock	-20	-18.32	-	-	-	-
Total Common Equity	1,407	1,411	1,489	1,497	1,479	1,396
Minority Interest	13.29	14.33	18.34	-	-5.89	-0.15
Shareholders' Equity	1,420	1,426	1,507	1,497	1,473	1,396
Total Liabilities & Equity	1,561	1,554	1,594	1,605	1,598	1,514
Total Debt	16.05	15.49	1.25	0.45	0.51	-
Net Cash (Debt)	125.14	174.53	206.1	357.42	467.78	587.07
Net Cash Growth	-27.28%	-15.32%	-42.34%	-23.59%	-20.32%	-10.78%
Net Cash Per Share	0.29	0.43	0.52	0.88	1.15	1.41
Filing Date Shares Outstanding	410.64	407.53	410.64	410.64	379.56	409.7
Total Common Shares Outstanding	410.64	407.53	410.64	410.64	379.56	409.7
Working Capital	413.54	434.63	521.79	608.29	619.93	687.99
Book Value Per Share	3.43	3.46	3.63	3.65	3.90	3.41
Tangible Book Value	1,306	1,309	1,395	1,444	1,446	1,363
Tangible Book Value Per Share	3.18	3.21	3.40	3.52	3.81	3.33
Buildings	-	343.74	318.94	298.9	285.68	225.1
Machinery	-	600.61	595.91	577.97	495.93	436.53
Construction In Progress	-	177.87	163.44	98.95	133.78	92.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.